Article Details

Galinpepimut-S Plus Nivolumab Shows Promising Preliminary Benefit in Mesothelioma

Retrieved on: 2021-06-28 17:56:49

Tags for this article:

Click the tags to see associated articles and topics

Galinpepimut-S Plus Nivolumab Shows Promising Preliminary Benefit in Mesothelioma. View article details on hiswai:

Excerpt

When given to patients, the immune response induced by galinpepimut-S possesses the potential to identify and eliminate cancer cells and provide ...

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo